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Introduction
The acute encephalitis syndrome has heralded the emer-
gence of multiple virulent pathogens in Australia, includ-
ing Murray Valley encephalitis, and recently Hendra virus
and Australian bat lyssavirus. In Australia, the encephalitis
syndrome in humans is not notifiable. The burden of Aus-
tralian encephalitis hospitalisations and deaths was not
known; encephalitis aetiology and trends had not been
investigated at population level; and the adequacy of neu-
rological review in hospitalised encephalitis cases to
exclude emerging pathogens had not been investigated.
Materials and methods
A series of studies was conducted to better understand the
status of encephalitis surveillance in Australia. Firstly,
Australian Bureau of Statistics mortality and population
data for the period 1979–2006 were obtained and cause of
death data were extracted using ICD-9 (1979–1998) and
ICD-10 (1999–2006). Secondly, rates of hospitalisation for
patients with encephalitis in Australia’s most populous
state, New South Wales (NSW), from January 1990
through to December 2007 were reviewed, with encephali-
tis-associated hospital stays extracted using ICD-9-CM
(1990–1998) and ICD-10-AM (1999–2007) from the
NSW Department of Health Inpatient Statistics Collection
library. Finally, a retrospective clinical audit was per-
formed, of all adult encephalitis admissions between July
1998 and December 2007 to the three hospitals with adult
neurological services in northern NSW. Case notes were
examined for evidence of relevant history taking, clinical
features, physical examination, laboratory and neuroradiol-
ogy investigations, and outcomes.
Results
Between 1979 and 2006 there were 1,118 encephalitis-
associated deaths in Australia, with an average annual
death rate of 2.3 per million population. The aetiology of
576 deaths was unknown and the proportion of deaths
due to ‘unknown’ encephalitis increased from 47.0%
between 1979 and 1992, to 57.2% from 1993 to 2006.
Encephalitis was the primary discharge diagnosis for 5,926
hospital admissions in NSW with an average annual hospi-
talisation rate of 5.2/100,000 population. Toxoplasma
encephalitis and subacute sclerosing panencephalitis
showed notable declines. The proportion of patients hos-
pitalised with encephalitis and no identified pathogen
(69.8%, range 61.5%–78.7%) was stable during the study
period. Amongst patients admitted with an encephalitis
diagnosis in the NSW regional neurological hospital net-
work, treating clinicians suspected a specific causative
organism in 18.9% of cases and a cause was confirmed by
laboratory testing in 12.1% of cases. However, only 14.9%
were tested for flaviviruses and tests for specific locally
occurring zoonotic encephalitis viruses were only con-
ducted in 0.0-6.8% of cases.
Conclusions
The non-notifiable status of human encephalitis in Austra-
lia and the high proportion of cases, including deaths, with
no known aetiology may conceal emergence of novel
pathogens. Unexplained encephalitis should be investi-
gated, and encephalitis hospitalisations should be subject
to statutory notification to facilitate prompt public health
investigation and action as necessary. The utility of hospi-
tal sentinel surveillance, and standardised diagnostic and
testing algorithm is currently being explored.
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